Statewide

Generosity from anonymous donors will support research and aid in the development of new treatments for hard-to-treat or incurable diseases, to the benefit of patients everywhere.

Generosity from anonymous donors will support research and aid in the development of new treatments for hard-to-treat or incurable diseases, to the benefit of patients everywhere.

UVA Licensing & Ventures Group helps UVA researchers secure patents for their inventions and launch start-up companies.

The Innovation Award honors breakthrough product development that significantly improves election verification and auditing. The program provides hands-on training and unmatched real-world experience.

The CCI awarded 18 seed grants to nine Virginia public universities for a total of $1.61M to address how artificial intelligence can make networks more secure, create new vulnerabilities, and more.

The Commonwealth BioAccelerator officially opened its doors, transforming 6,500 square feet of cutting-edge lab space into a launchpad for Virginia's most promising biotech ventures.

CvilleBioHub, a regional, industry-led organization, received a $4.3 million GO Virginia award and is partnering with UVA to establish the region's first laboratory accelerator at North Fork.

As part of the new institute, UVA's Biocomplexity Institute (BI) is contributing innovative AI research and solutions that will bolster efforts to detect illicit financial activity and address vulnerabilities within global supply chains.

To meet demand, Virginia is scaling up initiatives to develop and expand the workforce, including university-led development programs like the Commonwealth Cyber Initiative (CCI).

The Office of the Director of National Intelligence was the catalyst for the institute, with the goal of using next-gen technology to identify potential security threats and protect Americans.

The UVA Manning Institute of Biotechnology positions UVA at the very forefront of cutting-edge medicine, such as cellular and gene therapies that revolutionize how diseases are treated and cured.

Melissa M. Lubin will lead UVA's School of Continuing and Professional Studies (SCPS) as Dean with emphasis on programs that respond to both student and workforce demand.